Eyeworld

30 | EYEWORLD | SPRING 2026 ASCRS NEWS ASCRS ANNUAL MEETING PREVIEW About the physicians Daniel Chang, MD Cataract and Refractive Surgeon Empire Eye and Laser Center Bakersfield, California Marjan Farid, MD Director of Cornea, Cataract, and Refractive Surgery Gavin Herbert Eye Institute University of California, Irvine Irvine, California Manjool Shah, MD Clinical Associate Professor Kellogg Eye Center University of Michigan Ann Arbor, Michigan soon, Dr. Farid said a staple of Cornea Day is continuing to review best practices in the management of surgical cornea and office-based corneal disease. Glaucoma Day This year's Glaucoma Day program will again feature a mix of relevant topics in the glaucoma field, covering both clinical and surgical topics. The ASCRS/AGS Joint Symposium will kick off the day, covering a variety of hot topics, like AI and robotics and potential applications in glaucoma, what's new in minimally invasive bleb surgery, the future of MIGS, and more. The "Glaukomtecken" session will highlight the latest and greatest in glaucoma diagnos- tics. Technologies like OCT, gonioscopy im- aging, virtual visual fields, AI, and more will be discussed. Another morning session will explore medications, lasers, and lifestyle and will feature discussion relating to interventional glaucoma (including where medications fit in), drug delivery, and available laser procedures. Afternoon sessions will include a surgical spotlight, which will feature video presenta- tions on topics like repairing cyclodialysis clefts, suprachoroidal outflow procedures, canal-based MIGS devices, gonioprisms, and more. This year, the Stephen A. Obstbaum, MD, Honored Lecture will be given by Steven Sarkisian, MD. The final session of the day will be the popular "Complications and a Reay of Hope" video session, where presenters will share their complications via video case presentations, and audience members will vote for the best video at the end of the session. "I'm really looking forward to this day. It is a highlight of the year for me and a place where I can not only catch up with friends and colleagues, but also pick up a pearl or clinical insight that I can bring directly back to the op- erating room the following week," said Manjool Shah, MD, co-chair of Glaucoma Day. "From cutting-edge technology to figuring out how to be better with what we already have, Glaucoma Day will not disappoint. I look forward to seeing you all there!" ASCRS Subspecialty Day preview continued on page 32 A SCRS Subspecialty Day will take place on Friday, April 10, ahead of the 2026 ASCRS Annual Meeting, and promises exciting content across the fields of cornea, glaucoma, and refractive surgery. Cornea Day "Cornea Day is going to be fantastic in 2026," said Marjan Farid, MD, co-chair of the program. "We have a very diverse program that's going to address everything in cornea." The program will start with a deep dive into surgical approach- es for various types of keratoplasty, including novel keratoprosthesis that are in the design phase and updates on development. Advanced treatments for endothelial disease, including products like EndoArt (EyeYon Medical)—an artificial endothelial layer and synthetic implant to treat corneal edema—and updates on inject- able endothelial cell therapy and where they are in development will be highlighted. "We're ex- cited to see these technologies come into clinical practice," she said. "Additionally, we are going to do a deep dive into keratoconus. We will explore novel diagnostics and treatments, including the latest data on epi-on crosslinking and techniques for best surgical practices to bring refractive options to these patients," she said. "The morning session will end by examining treatments for the management of severe ocular surface disease, including persistent corneal epithelial defects and neurotrophic kerati- tis. We will also review best practices for the management of limbal stem cell deficiency," Dr. Farid said. "The afternoon program will cover a variety of office-based diseases, including the management of various infectious and non-in- fectious keratitis, ocular surface tumors, and we will highlight what's new in dry eye disease, including the updated ASCRS Preoperative OSD Algorithm." The second annual Holland Lecture will be featured, with Mark Mannis, MD, giving the lecture this year. His lecture will be titled "Elec- trotherapy and Ocular Surface Disease: Is it in Our Future? In addition to focusing on some of the new technologies that will hopefully be available

• Cover